awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34111719-40DB205C-CCF6-4C4E-B137-DDCEEF28CA6A
Q34111719-40DB205C-CCF6-4C4E-B137-DDCEEF28CA6A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34111719-40DB205C-CCF6-4C4E-B137-DDCEEF28CA6A
LUD 00-009: phase 1 study of intensive course immunization with NY-ESO-1 peptides in HLA-A2 positive patients with NY-ESO-1-expressing cancer.
P2860
Q34111719-40DB205C-CCF6-4C4E-B137-DDCEEF28CA6A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34111719-40DB205C-CCF6-4C4E-B137-DDCEEF28CA6A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8daa8eb93b5ffe8dc3da61f479df71a98111fba4
P2860
CD8(+) T cell responses against a dominant cryptic HLA-A2 epitope after NY-ESO-1 peptide immunization of cancer patients.